1. Home
  2. PHVS vs PEB Comparison

PHVS vs PEB Comparison

Compare PHVS & PEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pharvaris N.V.

PHVS

Pharvaris N.V.

HOLD

Current Price

$29.73

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Pebblebrook Hotel Trust of Beneficial Interest

PEB

Pebblebrook Hotel Trust of Beneficial Interest

SELL

Current Price

$12.70

Market Cap

1.5B

Sector

Real Estate

ML Signal

SELL

Company Overview

Basic Information
Metric
PHVS
PEB
Founded
2015
2009
Country
Switzerland
United States
Employees
N/A
60
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
PHVS
PEB
Price
$29.73
$12.70
Analyst Decision
Buy
Hold
Analyst Count
10
10
Target Price
$40.70
$12.80
AVG Volume (30 Days)
155.6K
2.2M
Earning Date
05-12-2026
04-28-2026
Dividend Yield
N/A
0.32%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.32
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.51
$7.41
52 Week High
$29.80
$13.35

Technical Indicators

Market Signals
Indicator
PHVS
PEB
Relative Strength Index (RSI) 65.28 54.85
Support Level $24.55 $11.93
Resistance Level $29.80 $12.80
Average True Range (ATR) 1.34 0.42
MACD 0.32 0.03
Stochastic Oscillator 91.13 82.37

Price Performance

Historical Comparison
PHVS
PEB

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

About PEB Pebblebrook Hotel Trust of Beneficial Interest

Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,933 rooms across 46 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.

Share on Social Networks: